RxDoctor Payments Data

Jennifer Bollyky, MD

Internal Medicine · Stanford, CANPI 1497717748

Payments from drug & device makers

What this record shows

That places this record below the midpoint for internal medicine clinicians in CA, where the typical reported total is $147.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$271,725in research payments, 2019–2025

Across 3 payments — averaging $90,575 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$272K

How this compares

$0 in reported general payments places this provider in the 20th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Medicare billing

Part B allowed, 2024
$22,384
Medicare patients
204
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate11$171
Naproxen12$56
Lisinopril11$31

Paid to pharmacies, not to this prescriber.

Other internal medicine in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →